LISAFTOCLAX

Clinical trials for LISAFTOCLAX explained in plain language.

Never miss a new study

Get alerted when new LISAFTOCLAX trials appear

Sign up with your email to follow new studies for LISAFTOCLAX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for leukemia patients who have run out of options

Disease control Not yet recruiting

This early-stage study aims to find safe doses of two new drugs, lisaftoclax and pelcitoclax, when combined with a standard chemotherapy called FLAG. It is for adults whose T-cell acute lymphoblastic leukemia (T-ALL) has come back or hasn't responded to previous treatments. The m…

Matched conditions: LISAFTOCLAX

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

LISAFTOCLAX

Get alerted when new LISAFTOCLAX trials appear

New hope for leukemia patients who have run out of options